SEC Tracker
Get the app

Compass Therapeutics CMPX

The Biotech Growth Trust (Director) plans to sell 3,571,428 CMPX shares, about $5.7M

Form
144
Filed
Importance
Routine
  1. Approximate sale date: Apr 9, 2025
  2. Broker: Jefferies LLC
  3. Shares acquired by: Public Offering

All of The Biotech Growth Trust's insider filings, holdings and planned sales

Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Compass Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Ocugen OCGN public float $279M, Jun 30, 2025
  2. Abeona Therapeutics ABEO public float $273M, Jun 30, 2025
  3. Tonix Pharmaceuticals Holding TNXP public float $271M, Jun 30, 2025
  4. Vanda Pharmaceuticals VNDA public float $269M, Jun 30, 2025
  5. Standard Biotools LAB public float $291M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.